MX:1093N Stock Latest News
Company AnnouncementsCSPC Begins Phase II China Trial of SYH2072 for Hypertension1d ago
Company AnnouncementsCSPC Initiates China Phase I/II Trial of SYS6088 Cancer Therapy1d ago
Company AnnouncementsCSPC Begins Phase I Trial of Recombinant RSV Vaccine in China2d ago
Company AnnouncementsCSPC Begins Phase I/II Trial of SYS6052 Herpes Zoster Vaccine2d ago
Company AnnouncementsCSPC Diabetes Triple Therapy Achieves Positive Phase III Results2d ago
Company AnnouncementsCSPC launches Phase I/II trial for new B7‑H3 ADC in China5d ago
Company AnnouncementsCSPC’s Novel Immuno-Oncology Drug Shows Early Promise in Advanced Solid Tumours1w ago
Company AnnouncementsCSPC’s B7-H3 ADC Shows Strong Phase I/II Results in Advanced Breast Cancer1w ago
Company AnnouncementsCSPC’s Anbenitamab Delivers Major Survival Gain in HER2-Positive Gastric Cancer Trial1w ago- Company AnnouncementsCSPC’s Anbenitamab Combo Delivers Superior Results in HER2-Positive Breast Cancer Trial1w ago
Company AnnouncementsCSPC Wins China Approval for First-in-Class Batoclimab Therapy in Myasthenia Gravis1w agoCompany AnnouncementsCSPC Launches Phase III Trial for Novel Triple-Negative Breast Cancer Drug in China1w ago
Company AnnouncementsCSPC Launches Phase I Trial of Dual-Target Dry Eye Drug SYH2083 in China2w ago
Company AnnouncementsCSPC Pharma Grants 78 Million Restricted Shares Under 2026 Incentive Scheme2w ago- Company AnnouncementsCSPC Wins China Trial Nod for Innovative Trispecific Cancer Antibody2w ago
Company AnnouncementsCSPC Grants 33.98 Million Restricted Shares Under Long-Term Incentive Plan2w ago
Company AnnouncementsCSPC Wins China Trial Nod for New Cancer Antibody-Drug Conjugate2w agoCompany AnnouncementsCSPC Advances Nectin-4 ADC SYS6002 in Cervical Cancer After Positive Phase I Data3w ago
